Financial News · Live Terminal

Page 496 of 532

BofA Securities Adjusts Price Target on Masco to $61 From $69

Masco (MAS) has an average rating of overweight and mean price target of $76.72, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $65.65, Change: $-0.94, Percent Change: -1.40%

$MAS

Wire111d ago

BofA Adjusts Price Target on Whirlpool to $50 From $60

Whirlpool (WHR) has an average rating of hold and mean price target of $65.11, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $55.54, Change: $-1.29, Percent Change: -2.27%

$WHR

Wire111d ago

BofA Securities Adjusts Price Target on Hayward to $18 From $19

Hayward (HAYW) has an average rating of overweight and mean price target of $17.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $15.22, Change: $-0.05, Percent Change: -0.36%

$HAYW

Wire111d ago

BofA Securities Adjusts Price Target on Fortune Brands Innovations to $42 From $52

Fortune Brands Innovations (FBIN) has an average rating of hold and mean price target of $51.29, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $39.86, Change: $-0.57, Percent Change: -1.41%

$FBIN

Wire111d ago

Update: Cleveland-Cliffs Shares Fall After Company Reports Q1 Results

(Updates with the latest stock move in the headline and in the first paragraph, capital expenditure outlook in the sixth paragraph)Cleveland-Cliffs (CLF) shares were down 6.9% in early Monday trading after the steel producer reported its first-quarter results.The company posted a quarterly adjusted net loss of $0.40 per diluted share, narrowing from a loss of $0.93 a year earlier.Analysts polled by FactSet expected a loss of $0.43.Revenue for the quarter ended March 31 was $4.92 billion, up from $4.63 billion a year earlier.Analysts surveyed by FactSet expected $4.81 billion.The company said it maintained its expectation for 2026 capital expenditures of about $700 million. Four analysts polled by FactSet expect $705 million.Price: $9.20, Change: $-0.74, Percent Change: -7.44%

$CLF

Wire111d ago

Adobe Launches CX Enterprise to Streamline Customer Interactions

Adobe (ADBE) said Monday it unveiled CX Enterprise, an end-to-end agentic artificial intelligence system designed to help businesses manage their customer lifecycle workflows across fragmented platforms.The system targets to deliver better customer experiences and business results, the software firm said.Adobe is partnering with external platforms, including Amazon's (AMZN) Web Services, Alphabet-owned (GOOG, GOOGL) Google Cloud, Microsoft (MSFT), Nvidia (NVDA), International Business Machines (IBM), OpenAI and Anthropic to improve compatibility with existing enterprise environments, it said.The company also said it introduced the CX Enterprise Coworker application, which translates broad business goals into multi-step actions by coordinating various AI agents to assemble audiences, creative assets, and performance data.Shares of the company were up 2.6% in early Monday trading.Price: $250.67, Change: $+6.22, Percent Change: +2.54%

$ADBE$AMZN$GOOG$GOOGL$IBM$MSFT$NVDA

Wire111d ago

BofA Securities Adjusts Price Target on Armstrong World Industries to $210 From $216

Armstrong World Industries (AWI) has an average rating of overweight and mean price target of $206.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $179.71, Change: $+0.04, Percent Change: +0.02%

$AWI

Wire111d ago

BofA Securities Cuts Price Target on Meta Platforms to $820 From $885, Maintains Buy Rating

Meta Platforms (META) has an average rating of buy and mean price target of $847.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $675.22, Change: $-13.33, Percent Change: -1.94%

$META

Wire111d ago

BofA Securities Raises Price Target on Amazon.com to $298 From $275, Maintains Buy Rating

Amazon.com (AMZN) has an average rating of buy and mean price target of $281.85, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $247.36, Change: $-3.20, Percent Change: -1.28%

$AMZN

Wire111d ago

BofA Securities Adjusts Price Target on Allegion Public to $157 From $185

Allegion Public (ALLE) has an average rating of overweight and mean price target of $173.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $145.23, Change: $+0.91, Percent Change: +0.63%

$ALLE

Wire111d ago

AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge

AnaptysBio (ANAB) said Monday that it has completed the spinoff of its biopharma operations business First Tracks Biotherapeutics.Under the terms of the spinoff, Anaptys shareholders received one share of First Tracks for every share of Anaptys owned as of the close of business on April 6. First Tracks Bio common stock were set to begin trading Monday on the Nasdaq Global Select Market under the ticker symbol "TRAX."The company said it will now exclusively manage its financial collaborations with GSK (GSK) and Vanda for cancer medicine Jemperli and generalized pustular psoriasis treatment imsidolimab, respectively.Shares of AnaptysBio were up close to 8% in recent trading on Monday.Price: $48.39, Change: $+3.39, Percent Change: +7.53%

$ANAB$GSK$TRAX

Wire111d ago

Market Chatter: Eni, Repsol Reach Deal With Venezuela to Boost Output, Export LNG From Offshore Field

Eni (E) and Repsol have reached a deal with the Venezuelan government to begin exporting natural gas from the country's Perla field in the Gulf of Venezuela, shipping the fuel in the form of liquefied natural gas from a floating terminal, Bloomberg reported Monday, citing sources familiar with the matter.The deal, which was signed in mid-March, will allow the two companies to start exporting once they boost supplies for domestic use to 645 million cubic feet per day from 585 million currently. They plan to install two more platforms in the field by 2028 and begin exporting once they attain production of 1.2 billion cubic feet per day, the sources said.The two companies have also been assured that they will be compensated for billions of dollars worth of gas that they have extracted in the field for domestic use in the past years, according to the report. The agreement also extends their operation lease to 2051 from 2036, the sources said.The two companies aim to submit a final development plan for the field to state-owned oil firm Petroleos de Venezuela by June, the report said.Eni confirmed to Bloomberg that the companies reached an agreement with the government to boost gas production and begin exports.Eni and Repsol did not immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $52.42, Change: $+0.13, Percent Change: +0.25%

Wire111d ago

Choice Hotels International Collaborating With Amazon Web Services to Integrate AI in Its Operations

Choice Hotels International (CHH) said Monday it is integrating AI across its operations in collaboration with Amazon's (AMZN) Amazon Web Services.Financial details were not provided.Choice Hotels said it is using the AgentCore platform backed by AWS that allows it to use intelligent agents that can retrieve information and automate workflows.Price: $118.92, Change: $-0.29, Percent Change: -0.24%

$AMZN$CHH

Wire111d ago

Meta, CBRE Launch Data Center Workforce Training Program

Meta Platforms (META) and CBRE Group (CBRE) said Monday they have launched a multiyear program to recruit and train technicians to support the construction of Meta's data centers in the US.Financial terms of the partnership were not provided.The companies said CBRE will set up training sites across the country beginning this summer, with participants prepared for roles installing fiber-optic systems, network equipment, and other infrastructure at Meta data center projects.The program, dubbed LevelUp, is intended to address a shortage of skilled workers needed for data center construction, with trainees expected to work through Meta's contractor network, the companies said.Price: $675.70, Change: $-12.85, Percent Change: -1.87%

$CBRE$META

Wire111d ago

Silvaco Says SmartSpice Platform Deployed at Taiwan Incubation Center

Silvaco (SVCO) said Monday that its SmartSpice circuit simulation platform has been deployed by Taiwan-based Industrial Technology Research Institute at its Nankang IC Design Incubation Center.The company said SmartSpice will enable precise circuit simulation and verification for next-generation microcontroller unit designs developed by startups within the incubator program.Financial details related to the partnership were not provided.Shares of Silvaco were up 1% in early trading Monday.Price: $8.62, Change: $+0.09, Percent Change: +1.00%

$SVCO

Wire111d ago

Viasat Confirms Launch of Final ViaSat-3 Satellite

Viasat (VSAT) said Monday its ViaSat-3 F3 satellite is scheduled for launch on April 27, aboard a SpaceX Falcon Heavy rocket from NASA's Kennedy Space Center, marking the final satellite in its ViaSat-3 constellation.The satellite is designed to deliver over 1 terabit per second of throughput across the Asia-Pacific region, expanding Viasat's high-capacity broadband network for commercial, mobility and government customers.Following launch, it will undergo several months of orbit-raising and in-orbit testing before entering service, expected in late summer of this year.Shares of Viasat were up 1.2% in Monday trading.Price: $63.63, Change: $+0.78, Percent Change: +1.24%

$VSAT

Wire111d ago

Nano-X Imaging Signs Strategic Deal With Howard Technology to Rollout 3D Imaging System; Shares Fall Pre-Bell

Nano-X Imaging (NNOX) said Monday it has signed a strategic commercial agreement with Howard Technology Solutions to support the commercial rollout of its 3D medical imaging system Nanox.ARC.Financial terms of the agreement were not disclosed.Under the deal, Howard will market and deploy 300 Nanox.ARC systems over a three-year period, which will include 60 in the first year.Shares of Nano-X Imaging were down more than 14% pre-bell.Price: $2.45, Change: $-0.40, Percent Change: -14.04%

$NNOX

Wire111d ago

Rayonier Advanced Materials Explores Strategic Moves; Creates Interim Office of Chief Executive

Rayonier Advanced Materials (RYAM) said Monday it is exploring a strategic alternatives that could include selling all or part of the company, a strategic investment, a merger or other business combination, and other strategic or financial alternatives."The board has not set a timetable for completion of the strategic review and does not intend to provide updates unless and until it is determined that disclosure is appropriate or required by law," Rayonier said in a statement.The company also said that its board of directors has set up an interim office of the chief executive following the resignation of President and Chief Executive Scott Sutton.The office includes Chief Financial Officer Marcus Moeltner, Vice President of Manufacturing Operations Michael Osborne, Senior Vice President of Biomaterials Christian Ribeyrolle, and General Counsel R. Colby Slaughter.Shares of Rayonier Advanced Materials were up over 5% pre-bell Monday.Price: $10.80, Change: $+0.59, Percent Change: +5.78%

$RYAM

Wire111d ago

Sable Offshore Expects $180 Million in Capital Expenditures Through December, Oil Transportation Begins

Sable Offshore (SOC) said Monday that capital expenditure across its assets is expected to be around $180 million from April through December this year.The company also said oil transportation through two segments of the Santa Ynez Pipeline System has begun.The company said the 40 wells currently online at the Harmony and Heritage offshore platforms are producing an average of 750 barrels of oil per day per well.Once all 74 production wells are online, Sable said it expects average production per well to be around 700 barrels of oil per day.Sable also said it expects Platform Hondo to come online in June with an estimated fully ramped production rate of around 10,000 barrels of oil per day.The company also said it plans to conclude a refinancing of its senior secured term loan in the second quarter of 2026.Shares of the company were up 3.7% in Monday premarket trading.

$SOC

Wire111d ago

Prelude Therapeutics Prices $90 Million Underwritten Offering

Prelude Therapeutics (PRLD) said Monday it has priced an underwritten offering of about 18 million shares of voting common stock at $4.44 per share, along with pre-funded warrants to purchase up to about 2.3 million shares at $4.4399 each, for gross proceeds of about $90 million.The offering is expected to close on or about Tuesday, the company said.Net proceeds will be used for working capital and general corporate purposes, including the development of its product candidates, Prelude Therapeutics said.Shares of Prelude Therapeutics were 11% higher in Monday premarket trading.

$PRLD

Showing 9901-9920 of 10633